SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Paul Jansen who wrote ()6/19/1996 11:28:00 PM
From: Joel W. Hunt   of 123
 
Paul, What happened to John W. Fara who was the CEO of Anergen for the last five years?? Was he run completely from the company? I bought some of Anergen during the 10/91 buying frenzy that saw the stock go up to the low 30's. I got in at 25 and have held onto them out of shame (one of my first stock blunders) to tell you the truth. They have some good drugs in the pipeline: RA- AnervaX for Rheumatoid Arthritis and MS-AnergiX for Multiple Sclerosis (these are the two most promising drugs being developed at this time). Others include variations of the AnergiX for Myasthenia Gravis and Inflammatory Bowel Disease. The MS-AnergiX expects to begin phase I/II this year. Contact Anergen at: 301 Penobscot Drive Redwood City, CA 94063 (415) 361-8901 or Fax 415 361-8958. Hope this was a little informative to you. Am I holding on to my shares? Why not at this price....Who knows Joel
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext